A phase I-II, open-label, multicenter trial to determine the dosimetry and safety of 99mTc-sestamibi in pediatric subjects

Sayena Azarbar, Arash Salardini, Nagib Dahdah, Joel Lazewatsky, Richard Sparks, Michael Portman, Paul D. Crane, Meng Luen Lee, Qi Zhu

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Fingerprint

Dive into the research topics of 'A phase I-II, open-label, multicenter trial to determine the dosimetry and safety of 99mTc-sestamibi in pediatric subjects'. Together they form a unique fingerprint.

Medicine and Dentistry

Nursing and Health Professions

Biochemistry, Genetics and Molecular Biology

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology